Hepatic encephalopathy

British Journal of Hospital Medicine

Volumn 73, Issue 2, 2012, Pages 79-85

  Patel, D ^a   Cobbold, J F L ^a   Taylor Robinson, S D ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84857888225     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2012.73.2.79     Document Type: Conference Paper

References (46)

1. Ahboucha S, Butterworth RF (2004) Pathophysiology of hepatic encephalopathy: A new look at GABA from the molecular standpoint. Metab Brain Dis 19(3/4):331-43 (Pubitemid 39361191)
2. Ahboucha S, Desjardins P, Chatauret N, Pomier-Layrargues G, Butterworth RF (2003) Normal coupling of brain benzodiazepine and neurosteroid modulatory sites on the GABA-A receptor complex in human hepatic encephalopathy. Neurochem Int 43:551-6 (Pubitemid 36724953)
3. Albrecht J, Jones EA (1999) Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J Neurol Sci 170:138-46
4. Albrecht J, Norenberg MD (2006) Glutamine: A Trojan horse in ammonia neurotoxicity. Hepatology 44(4):788-94 (Pubitemid 46489541)
5. Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C (2003) Branched chain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev Issue 2:CD001939
6. Bajaj JS (2010) Review article: the modern management of hepatic encephalopathy. Aliment Pharmacol Ther 31:537-47
7. Bajaj JS, Wade JB, Sanyal A (2009) Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology 50(6):2014-21
8. Bajaj JS, Heuman DM, Wade JB et al (2011) Rifaxamin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterolog y 140(2):478-87.e1
9. Bass NM (2007) Review article: the current pharmacological therapies for hepatic encephalopathy. Aliment Pharmacol Ther 25(Suppl. 1):23-31 (Pubitemid 46148242)
10. Bass NM, Mullen KD, Sanyal A et al (2010) Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362:1071-81
11. Bassett ML, Mullen KD, Scholz B, Fenstermacher JD, Jones EA (1990) Increased brain uptake of gamma-aminobutyric acid in a rabbit model of hepatic encephalopathy. Gastroenterology 98:747-57 (Pubitemid 20069714)
12. Berding G, Banati RB, Buchert R et al International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) (2009) Radiotracer imaging studies in hepatic encephalopathy: ISHEN practice guidelines. Liver Int 29(5):621-8
13. Blei AT, Cordoba J, The Practice Parameters Committee of the American College of Gastroenterology (2001) Practice guidelines: Hepatic encephalopathy. Am J Gastroenterol 96(7):1968-76
14. Conn HO, Bircher J, eds (1994) Hepatic Encephalopathy: Syndromes and Therapies. Medi-Ed Press, Bloomington IL
15. Faint V (2006) The pathophysiology of hepatic encephalopathy. Nurs Crit Care 11(2):69-74
16. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT (2002) Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th world congress of gastroenterology, Vienna, 1998. Hepatology 35(3):716-21 (Pubitemid 34183979)
17. Fleming KM, Aithal G P, Solaymani-Dodaran M, Card TR, West J (2008) Incidence and prevalence of cirrhosis in the UK 1992-2001: a population based study. J Hepatol 49(5):732-8
18. Haussinger D, Schliess F (2008) Pathogenetic mechanisms of hepatic encephalopathy. Gut 57:1156-65
19. James JH (2002) Branched chain amino acids in hepatic encephalopathy. Am J Surg 183:424-9 (Pubitemid 34442508)
20. Jayakumar AR, Rao KV, Murthy ChR, Norenberg MD (2006) Glutamine in the mechanism of ammonia-induced astrocyte swelling. Neurochem Int 48:623-8
21. Jiang Q, Jiang XH, Zheng MH (2009) L-Ornithine-L-Aspartate in the management of heptic encephalopathy: a meta-analysis. J Gastroenterol Hepatol 24(1):9-14
22. Jones EA (2000) Pathogenesis of hepatic encephalopathy. Clin Liver Dis 4(2):467-85 (Pubitemid 30460833)
23. Larsen FS, Wendon J (2002) Brain oedema in liver failure: basic physiologic principles and management. Liver Transpl 8(11):983-9 (Pubitemid 35363623)
24. Mardini H, Saxby BK, Record CO (2008) Computerised psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant. Gastroenterology 135(5):1582-90
25. Mas A (2006) Hepatic encephalopathy: From pathophysiology to treatment. Digestion 73(Suppl 1):86-93
26. Moldawer LL, Marano MA, Wei H et al (1989) Cachectin/tumour necrosis factor-alpha alters red blood cell kinetics and induces anaemia in vivo. FASEB J 3:1637-43 (Pubitemid 19077641)
27. Mooney S, Hasssanein TI, Hilsabeck RC, Ziegler EA, Carlson M, Maron LM, Perry W; UCSD Hepatology Neurobehavioral Research Program (2007) Utility of the repeatable battery for the assessment of neuropsychological status (RBANS) in patients with end-stage liver disease awaiting liver transplantation. Arch Clin Neuropsycholog 22:175-86 (Pubitemid 46356880)
28. Morgan MH, Read AE, Speller DC (1982) Treatment of hepatic encephalopathy with metronidazole. Gut 23(1):1-7 (Pubitemid 12170168)
29. Muto Y, Sato S, Watanabe A et al; Long-Term Survival Study Group (2005) Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 3:705-13 (Pubitemid 40984733)
30. Neuberger J, Gimson A, Davies M, Akyol M, O'Grady J, Burroughs A, Hudson M; Liver Advisory Group; UK Blood and Transplant (2008) Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 57(2):252-7 (Pubitemid 351158055)
31. O'Grady JG, Schalm SW, Williams R (1993) Acute liver failure: redefining the syndromes. Lancet 342(8866):273-5 (Pubitemid 23224421)
32. Prakash R, Mullen KD (2010) Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 7:515-25
33. Riordan SM, Williams R (2008) Treatment of hepatic encephalopathy. N Engl J Med 337(7):473-9
34. Randolph C, Hisabeck R, Kato A et al (2009) Neuropsychiatric assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 29(5):629-35
35. Shawcross D, Davies NA, Williams R, Jalan R (2004) Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonaemia in cirrhosis. J Hepatol 40(2):247-54 (Pubitemid 38115829)
36. Shawcross D, Jalan R (2005a) Dispelling myths in the treatment of hepatic encephalopathy. Lancet 365:431-3 (Pubitemid 40179231)
37. Shawcross D, Jalan R (2005b) The pathophysiological basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell Mol Life Sci 62:2295-304 (Pubitemid 41500545)
38. Shukla S, Shukla A, Mehboob S, Guha S (2011) Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharm Ther 33(6):662-71
39. Sidhu SS, Goyal O, Mishra B P, Sood A, Chhina RS, Soni RK (2011) Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (The RIME Trial). Am J Gastroenterol 106:307-16
40. Sorrell JH, Zolnikov BJ, Sharma A, Jinnai I (2006) Cognitive impairment in people diagnosed with end-stage liver disease evaluation for liver transplant. Psychiatry Clin Neurosci 60:174-81
41. Stewart CA, Smith GE (2007) Minimal hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 4(12):677-85 (Pubitemid 350193817)
42. Taylor-Robinson SD, Oatridge A, Hajnal JV, Burroughs AK, McIntyre N, deSouza NM (1995) MR imaging of basal ganglia in chronic liver disease: correlation of T1-weighted and magnetization transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab Brain Dis 10(2):175-88
43. Trey C, Davidson CS (1970) The management of fulminant hepatic failure. Prog Liver Dis 3:282-98
44. Weissenborn K, Ennen JC, Schomerus H et al (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34(5):768-73 (Pubitemid 32488796)
45. Wright G, Shawcross D, Olde Damink SW, Jalan R (2007) Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension. Metab Brain Dis 22(3-4):375-88 (Pubitemid 47624323)
46. Zwingmann C, Chaturet N, Leibfritz D, Butterworth RF (2003) Selective increase of brain lactate synthesis in experimental acute liver failure: results of a (H-C) nuclear magnetic resonance study. Hepatology 37:420-8 (Pubitemid 36152542)